{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:41:44Z","timestamp":1793738504651,"version":"4.6.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.tcm.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:48:27Z","timestamp":1741798107000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of angina pectoris"],"prefix":"10.1016","author":[{"given":"Riccardo","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-1018","authenticated-orcid":false,"given":"Rocco A.","family":"Montone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2025.03.001_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/heartjnl-2018-314661","article-title":"Angina: contemporary diagnosis and management","volume":"106","author":"Ford","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2025.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0003","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00392-013-0568-z","article-title":"Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris","volume":"102","author":"Jespersen","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2019.09.013","article-title":"Impact of stable angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey","volume":"70","author":"Manolis","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-019-0233-y","article-title":"The myth of \u201cstable\u201d coronary artery disease","volume":"17","author":"Fox","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0006","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0007","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of Ischemic Heart Disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.03.001_bib0008","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0009","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jacc.2024.06.015","article-title":"Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions","volume":"84","author":"Montone","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0010","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2020.08.078","article-title":"Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review","volume":"76","author":"Ferraro","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0011","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0012","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0013","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2310610","article-title":"A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina","volume":"389","author":"Rajkumar","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(21)02045-6","article-title":"What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?","volume":"399","author":"Boden","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.120.017381","article-title":"Achieving Optimal Medical Therapy: Insights From the ORBITA Trial","volume":"10","author":"Foley","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.03.001_bib0019","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2020.05.016","article-title":"Prevalence of angina and use of medical therapy among US adults: A nationally representative estimate","volume":"228","author":"Aggarwal","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22594","article-title":"Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease","volume":"39","author":"Shen","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005455","article-title":"Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program","volume":"12","author":"Xie","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.tcm.2025.03.001_bib0022","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijcard.2016.06.150","article-title":"Medical treatment of stable angina: A tailored therapeutic approach","volume":"220","author":"Manolis","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0024","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(21)02045-6","article-title":"What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?","volume":"399","author":"Boden","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0025","article-title":"Medication adherence in cardiovascular medicine","volume":"374","author":"Simon","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2025.03.001_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2025.03.001_bib0027","first-page":"356","article-title":"The coronary sinus reducer improves angina symptoms in patients with stable CAD","volume":"21","author":"Huynh","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0028","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0029","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(24)00256-3","article-title":"Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial","volume":"403","author":"Foley","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0030","article-title":"Coronary Sinus Narrowing for Treating Refractory Angina: REDUCER-I Multicenter \u201cReal-World\u201d Observational Study Primary Endpoint Analysis","author":"Verheye","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2025.03.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2024.09.031","article-title":"Alleviating Refractory Angina Through Coronary Sinus Narrowing: Consistent Benefits and the Pursuit of Mechanistic Insights","author":"And\u00f2","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2025.03.001_bib0032","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehy857","article-title":"Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization","volume":"40","author":"Crea","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0033","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/2047487318777435","article-title":"Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents","volume":"25","author":"Montone","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0034","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","article-title":"Angina after percutaneous coronary intervention: The need for precision medicine","volume":"248","author":"Niccoli","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijcard.2020.04.074","article-title":"Myocardial ischemia: From disease to syndrome","volume":"314","author":"Marzilli","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0036","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0037","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1093\/eurheartj\/ehab282","article-title":"Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group","volume":"42","author":"Shimokawa","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0038","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of Coronary Microvascular Dysfunction","volume":"86","author":"Crea","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0039","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.31083\/j.rcm2311371","article-title":"Invasive Functional Coronary Assessment in Myocardial Ischemia with Non-Obstructive Coronary Arteries: from Pathophysiological Mechanisms to Clinical Implications","volume":"23","author":"Rinaldi","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0041","doi-asserted-by":"crossref","first-page":"E666","DOI":"10.4244\/EIJ-D-21-00971","article-title":"Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2025.03.001_bib0042","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0043","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0044","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0045","article-title":"Angina or ischemia with no obstructed coronary arteries: a specific diagnostic and therapeutic protocol","author":"Rinaldi","year":"2024","journal-title":"REC: Interventional Cardiology (English Edition)"},{"key":"10.1016\/j.tcm.2025.03.001_bib0046","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCULATIONAHA.123.066680","article-title":"ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial","volume":"149","author":"Sinha","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.03.001_bib0047","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0735-1097(93)90310-W","article-title":"Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group","volume":"21","author":"Chahine","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0048","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1253\/circj.CJ-10-0292","article-title":"Prognostic effects of calcium channel blockers in patients with vasospastic angina\u2013a meta-analysis","volume":"74","author":"Nishigaki","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0049","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jcmg.2022.03.012","article-title":"Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial","volume":"15","author":"Jansen","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2025.03.001_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030188","article-title":"Effect of Diltiazem Versus Placebo on Microvascular Dysfunction Assessed By Repeated Continuous Thermodilution Measurements: Results of the EDIT-CMD Trial","volume":"12","author":"Jansen","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.03.001_bib0051","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0735-1097(01)01510-8","article-title":"Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans","volume":"38","author":"Gori","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0052","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurheartj\/ehu313","article-title":"Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association","volume":"36","author":"Takahashi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0053","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.tcm.2025.03.001_bib0054","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.CIR.65.2.281","article-title":"Exacerbation of vasotonic angina pectoris by propranolol","volume":"65","author":"Robertson","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.03.001_bib0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0056","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/HJH.0b013e328340a08e","article-title":"Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension","volume":"29","author":"Neglia","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2025.03.001_bib0057","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003426","article-title":"Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm","volume":"5","author":"Ishii","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.03.001_bib0058","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0059","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9149(97)00279-8","article-title":"Effects of short-term treatment of Nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina","volume":"80","author":"Chen","year":"1997","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.tcm.2025.03.001_bib0061","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.03.001_bib0062","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(02)02632-3","article-title":"Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm","volume":"41","author":"Mohri","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0063","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/eurheartj\/ehz915","article-title":"Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction","volume":"41","author":"Ford","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0064","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.124.069901","article-title":"Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial","volume":"150","author":"Morrow","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.03.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020535","article-title":"Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications","volume":"10","author":"Montone","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.03.001_bib0066","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamacardio.2023.2566","article-title":"Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina: A Randomized Clinical Trial","volume":"8","author":"Ullrich","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0067","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013481","article-title":"Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study","volume":"17","author":"Tebaldi","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2025.03.001_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101803","article-title":"Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography","volume":"33","author":"Cheng","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcin.2024.09.018","article-title":"Coronary Sinus Reducer Improves Angina, Quality of Life, and Coronary Flow Reserve in Microvascular Dysfunction","author":"Tryon","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2025.03.001_bib0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0735-1097(97)00421-X","article-title":"Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X","volume":"31","author":"Pasceri","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph18042023","article-title":"Key Factors Associated with Adherence to Physical Exercise in Patients with Chronic Diseases and Older Adults: An Umbrella Review","volume":"18","author":"Collado-Mateo","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.tcm.2025.03.001_bib0072","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/heartjnl-2016-310750","article-title":"Heart and mind: behavioural cardiology demystified for the clinician","volume":"105","author":"Astin","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2025.03.001_bib0073","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jcmg.2023.03.007","article-title":"Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors: Systematic Review and Meta-Analysis","volume":"16","author":"Whitmore","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2025.03.001_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20031723","article-title":"Information Needs and Communication Strategies for People with Coronary Heart Disease: A Scoping Review","volume":"20","author":"Zwack","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.tcm.2025.03.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01647-2","article-title":"The effect of problem-based learning after coronary heart disease - a randomised study in primary health care (COR-PRIM)","volume":"20","author":"K\u00f6hler","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.tcm.2025.03.001_bib0076","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamacardio.2018.3680","article-title":"Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences","volume":"3","author":"Navar","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0077","article-title":"Smoking cessation for the secondary prevention of coronary heart disease","author":"Critchley","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tcm.2025.03.001_bib0078","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","article-title":"Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis","volume":"129","author":"Mills","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.03.001_bib0079","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tcm.2025.03.001_bib0080","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1177\/2047487320941993","article-title":"Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC)","volume":"28","author":"Kavousi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0081","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0082","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2025.03.001_bib0083","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0084","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0085","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4065\/80.9.1157","article-title":"Safety and efficacy of bariatric surgery in patients with coronary artery disease","volume":"80","author":"Lopez-Jimenez","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2025.03.001_bib0086","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0087","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2025.03.001_bib0088","article-title":"Psychological and pharmacological interventions for depression in patients with coronary artery disease","volume":"12","author":"Tully","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tcm.2025.03.001_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0090","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1177\/2047487320905719","article-title":"Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II)","volume":"27","author":"Salzwedel","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0091","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology","volume":"28","author":"Ambrosetti","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0092","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/eurjpc\/zwab007","article-title":"Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology","volume":"29","author":"Hansen","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0093","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s40279-018-0930-4","article-title":"Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group","volume":"48","author":"Hansen","year":"2018","journal-title":"Sports Med"},{"key":"10.1016\/j.tcm.2025.03.001_bib0094","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2021.09.008","article-title":"Air Pollution and Coronary Plaque Vulnerability and Instability: An Optical Coherence Tomography Study","volume":"15","author":"Montone","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2025.03.001_bib0095","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2022.08.744","article-title":"Air Pollution and Coronary Vasomotor Disorders in Patients With Myocardial Ischemia and Unobstructed Coronary Arteries","volume":"80","author":"Camilli","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.03.001_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117393","article-title":"Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study","volume":"390","author":"Rinaldi","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2025.03.001_bib0097","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/ehae001","article-title":"Exposome in ischaemic heart disease: beyond traditional risk factors","volume":"45","author":"Montone","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.03.001_bib0098","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2024.06.003","article-title":"Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach","volume":"85","author":"Montone","year":"2024","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T05:09:22Z","timestamp":1742706562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173825000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":98,"alternative-id":["S1050173825000337"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.03.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of angina pectoris","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}